Maltose-Neopentyl Glycol (MNG) les for Solubilization Stabilization and Crystallization of Membrane Proteins
Alchemist TM II: Capacity, reproducibility and efficiency of an high-throughput crystallization screen preparation system. Craig Sterling Director of Business.
Application of Phage Antibody Technology to Structural Genomics: Antibody Selection and Complex Formation Mark A. Sullivan Structural Genomics of Pathogenic.
Mark A. Sullivan Structural Genomics of Pathogenic Protozoa Center for Human Genetics and
Craig Sterling Director of Business Development Rigaku
Part 1. Production of Pure, Homogeneous and Stable Membrane Protein Larry Miercke, Rebecca Robbins, Mimi Ho, Andrew Sandstrom*, Rachel Bond, Bill Harries.
Part 1. Production of Pure, Homogeneous and Stable Membrane Protein
